Kestra Medical (KMTS) Director Traci Umberger Sells Shares
$KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.Research Summary
AI-generated summary of this SEC filing
Kestra Medical (KMTS) Director Traci Umberger Sells Shares
What Happened Traci S. Umberger — a director and the company's General Counsel & Chief Administrative Officer — sold a total of 22,229 Kestra Medical Technologies (KMTS) shares in open-market transactions to satisfy tax withholding tied to RSU vesting. The sales occurred on 2026-07-30 (5,887 shares at $22.74, $133,892), 2026-07-31 (8,752 shares at $22.60, $197,837), and 2026-08-03 (7,590 shares at $23.86, $181,062), totaling approximately $512,791.
Key Details
- Transaction dates and reported (weighted average) prices:
- 2026-07-30: 5,887 shares @ $22.74 = $133,892
- 2026-07-31: 8,752 shares @ $22.60 = $197,837
- 2026-08-03: 7,590 shares @ $23.86 = $181,062
- Total: 22,229 shares sold for ~$512,791.
- Shares owned after the transactions: not stated in the provided excerpt of the filing.
- Notable footnotes:
- F1: Sales were nondiscretionary "sell-to-cover" transactions to satisfy tax withholding on vested restricted stock units (RSUs).
- F2–F4: The filing reports weighted-average prices and gives price ranges for the underlying trades; the filer offers to provide per-price breakdowns on request.
- Filing: Form 4 filed 2026-08-03 reporting transactions from 2026-07-30 through 2026-08-03.
Context These were routine sell-to-cover transactions related to RSU settlement (tax withholding), which are common and do not necessarily indicate a change in the insider's view of the company. The filing is factual and tied to compensation tax obligations rather than an opportunistic market sale.